Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
245.44
+6.57 (2.75%)
Dec 20, 2024, 4:00 PM EST - Market closed

Alnylam Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
31,65724,02129,23820,28215,10012,840
Upgrade
Market Cap Growth
59.50%-17.84%44.16%34.32%17.60%74.32%
Upgrade
Enterprise Value
31,60324,27829,56419,87314,63911,424
Upgrade
Last Close Price
245.44191.41237.65169.58129.97115.17
Upgrade
PS Ratio
14.8513.1428.1824.0230.6458.43
Upgrade
PB Ratio
1091.32-108.87-184.7934.4814.868.92
Upgrade
P/TBV Ratio
1091.32--34.4814.868.92
Upgrade
P/FCF Ratio
1970.81572.67----
Upgrade
P/OCF Ratio
559.76230.62----
Upgrade
EV/Sales Ratio
15.0913.2828.5023.5429.7051.99
Upgrade
EV/FCF Ratio
1967.44578.81----
Upgrade
Debt / Equity Ratio
84.26-12.16-16.513.721.570.21
Upgrade
Debt / FCF Ratio
169.7263.96----
Upgrade
Asset Turnover
0.520.500.290.240.170.11
Upgrade
Inventory Turnover
3.572.851.571.731.190.62
Upgrade
Quick Ratio
2.572.863.163.794.234.48
Upgrade
Current Ratio
2.753.083.514.044.474.87
Upgrade
Return on Equity (ROE)
---526.14%-106.31%-69.92%-64.66%
Upgrade
Return on Assets (ROA)
-2.92%-4.78%-13.65%-12.56%-17.85%-29.58%
Upgrade
Return on Capital (ROIC)
-4.47%-7.17%-18.77%-16.46%-23.80%-38.19%
Upgrade
Earnings Yield
-1.05%-1.83%-3.87%-4.20%-5.68%-6.90%
Upgrade
FCF Yield
0.05%0.17%-2.10%-3.54%-4.54%-3.26%
Upgrade
Buyback Yield / Dilution
-1.97%-2.64%-2.73%-3.01%-5.24%-8.62%
Upgrade
Total Shareholder Return
-1.97%-2.64%-2.73%-3.01%-5.24%-8.62%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.